Side-by-side comparison of AI visibility scores, market position, and capabilities
DTC fresh dog food subscription with vet-formulated human-grade meals customized to each dog; $85M+ backed competing with The Farmer's Dog and Mars-owned Nom Nom for premium pet food subscriptions.
Ollie is a New York-based direct-to-consumer fresh dog food company delivering human-grade, veterinarian-formulated meals customized to each dog's individual nutritional profile — shipping refrigerated fresh-cooked food directly to customers' doors on a subscription basis at price points significantly above traditional pet food brands but positioned as a health investment for pet owners seeking better nutrition than processed kibble. Founded in 2016 and backed by over $85 million from investors including Canaan Partners, Primary Venture Partners, and Companion Fund, Ollie competes in the premium fresh pet food segment that has grown substantially as pet humanization trends have driven premiumization.
Global pharma company with $55B 2024 revenue; successfully diversifying beyond Humira with Skyrizi, Rinvoq, and $8.7B Cerevel neuroscience acquisition.
AbbVie is a global research-based biopharmaceutical company focused on developing treatments for complex and serious diseases including immunology, oncology, neuroscience, aesthetics, and eye care. Spun off from Abbott Laboratories in 2013 and headquartered in North Chicago, Illinois, AbbVie rapidly became one of the world's top pharmaceutical companies on the strength of Humira — the world's best-selling drug for over a decade with peak annual sales exceeding $20 billion. AbbVie is listed on the NYSE and is a component of the S&P 500 and Dow Jones Industrial Average.
Monitor how your brand performs across ChatGPT, Gemini, Perplexity, Claude, and Grok daily.